ALLE
46
2
PSX
32
-3
PYPL
64
-6
VMC
60
-5
FLR
65
10
GPC
44
-3
SYY
44
-3
TDC
59
-3
CNP
52
-10
IPG
42
11
AON
52
3
OI
39
-3
EQR
31
-2
HBI
49
-15
COF
48
-2
IFF
42
-2
NI
75
2
MET
61
-2
WEC
65
2
MAC
47
-3
ALLE
46
2
PSX
32
-3
PYPL
64
-6
VMC
60
-5
FLR
65
10
GPC
44
-3
SYY
44
-3
TDC
59
-3
CNP
52
-10
IPG
42
11
AON
52
3
OI
39
-3
EQR
31
-2
HBI
49
-15
COF
48
-2
IFF
42
-2
NI
75
2
MET
61
-2
WEC
65
2
MAC
47
-3
Financhill
Back

Lucid Diagnostics Stock Price Chart

Not Meta. Not Google. AI 2.0 Is Here, And It's Still Early.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio
Buy
55

LUCD
Lucid Diagnostics

Last Price:
$1.60
Seasonality Move:
0.7%

7 Day Trial

ALL ACCESS PASS

$ 7

Could BOXABL Be the Tesla of Housing?

Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LUCD is experiencing buying pressure, which is a positive indicator for future bullish movement.

Lucid Diagnostics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 1.32 Buy
20-day SMA: 1.26 Buy
50-day SMA: 1.35 Buy
200-day SMA: 1.04 Buy
8-day EMA: 1.35 Buy
20-day EMA: 1.3 Buy
50-day EMA: 1.29 Buy
200-day EMA: 1.14 Buy

Lucid Diagnostics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 70.29 Buy
Chaikin Money Flow: 2865076 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.18 - 1.36) Buy
Bollinger Bands (100): (0.98 - 1.48) Buy

Lucid Diagnostics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Lucid Diagnostics Stock

Is Lucid Diagnostics Stock a Buy?

  • Lucid Diagnostics share price is 1.59 while LUCD 8-day simple moving average is 1.32, which is a Buy signal.
  • The stock price of LUCD is 1.59 while Lucid Diagnostics 20-day SMA is 1.26, which makes it a Buy.
  • Lucid Diagnostics 50-day simple moving average is 1.35 while LUCD share price is 1.59, making it a Buy technically.
  • LUCD stock price is 1.59 and Lucid Diagnostics 200-day simple moving average is 1.04, creating a Buy signal.

LUCD Technical Analysis vs Fundamental Analysis

Buy
55
Lucid Diagnostics (LUCD) is a Buy

Is Lucid Diagnostics a Buy or a Sell?

  • Lucid Diagnostics stock is rated a Buy
    The current Lucid Diagnostics [LUCD] share price is $1.59. The Score for LUCD is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.

Lucid Diagnostics Stock Info

Market Cap:
161.6M
Price in USD:
1.59
Share Volume:
3.1M

Lucid Diagnostics 52-Week Range

52-Week High:
1.80
52-Week Low:
0.68
Buy
55
Lucid Diagnostics (LUCD) is a Buy

Lucid Diagnostics Share Price Forecast

Is Lucid Diagnostics Stock a Buy?

  • Lucid Diagnostics share price is 1.59 while LUCD 8-day exponential moving average is 1.35, which is a Buy signal.
  • The stock price of LUCD is 1.59 while Lucid Diagnostics 20-day EMA is 1.30, which makes it a Buy.
  • Lucid Diagnostics 50-day exponential moving average is 1.29 while LUCD share price is 1.59, making it a Buy technically.
  • LUCD stock price is 1.59 and Lucid Diagnostics 200-day simple moving average is 1.14, creating a Buy signal.

Fundamental Analysis of Lucid Diagnostics

Is Lucid Diagnostics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.02 per share, an increase this year of $0.31 per share, and an increase next year of $0.15 per share.

Technical Analysis of Lucid Diagnostics

Should I short Lucid Diagnostics stock?

* Lucid Diagnostics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.